HypertensionNCT07071077
Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans
A study testing Web-Based Storytelling Intervention and Group-Based Storytelling Plus Intervention in people with Hypertension, run by University of Delaware at 1 site in United States.
Trial summary
The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hypertension
- What is being tested?
- Web-Based Storytelling Intervention and Group-Based Storytelling Plus Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- 29 Jan 2025to 31 May 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- African American/Black
- Diagnosed with Hypertension
- Prescribed medication for hypertension
Who cannot join
- Cognitive limitations that limit the ability to provide informed consent
- Pregnancy
- Unable to speak or read English
- Planning to relocate during the study period
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Delaware
Newark, Delaware, 19713
Yendelela Cuffee, 302-831-1302, ylcuffee@udel.edu
Yendelela Cuffee
About this study
Official title: Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans With Hypertension
The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.
- Conditions
- Hypertension
- Being tested
- Web-Based Storytelling Intervention, Group-Based Storytelling Plus Intervention
- Keywords
- Medication Adherence, Lifestyle Intervention, Behavioral Change
- Medical subject headings
- Hypertension, Medication Adherence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Web-Based Storytelling InterventionBehavioural
The Web-based storytelling group will access stories and educational materials on the study website.
Group-Based Storytelling Plus InterventionBehavioural
The storytelling plus group will watch the stories in a group setting, share their experiences and have educational sessions led by a health coach.
| Study group | Role | What they receive |
|---|---|---|
| Usual Care | No intervention | Not described |
| Storytelling (Web-based Storytelling) | Experimental | Not described Receives: Behavioral: Web-Based Storytelling Intervention |
| Storytelling Plus (Group-based Storytelling) | Experimental | Not described Receives: Behavioral: Group-Based Storytelling Plus Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Systolic and Diastolic Blood Pressure
Blood pressure will be measured three times using a manual blood pressure monitor.
Measured: 6 months
Adherence to Antihypertensive Medications (daily usage)
Medication adherence will be measured using Medication Electronic Measuring System (MEMS) caps
Measured: 6 months
Adherence to Antihypertensive Medications (self reported)
Medication adherence will be measure through participant self report Domains of Subjective Extent of Nonadherence scale.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2025
- Study start29 Jan 2025
- Primary completion31 May 2026 (estimated)
- Study completion31 May 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Delaware
- Sponsor type
- University, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Responsible party
- Principal investigator, Yendelela Cuffee, University of Delaware
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07071077
- Sponsor's protocol ID
- 2034724-5
- Other IDs
- 5K01HL166372-02
- Status last verified
- Jul 2025
- First submitted
- 24 Feb 2025
- Last updated
- 17 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans With Hypertension
- ClinicalTrials.gov ID
- NCT07071077
- Acronym / sponsor ID
- 2034724-5
- Conditions
- Hypertension
- Keywords
- Medication Adherence, Lifestyle Intervention, Behavioral Change
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- University of DelawareUniversity, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Study start
- 29 Jan 2025 (actual)
- Primary completion
- 31 May 2026 (estimated)
- Study completion
- 31 May 2026 (estimated)
- First posted
- 17 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Usual Care | No intervention | – |
| Storytelling (Web-based Storytelling) | Experimental | Behavioral: Web-Based Storytelling Intervention |
| Storytelling Plus (Group-based Storytelling) | Experimental | Behavioral: Group-Based Storytelling Plus Intervention |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- African American/Black
- Diagnosed with Hypertension
- Prescribed medication for hypertension
Key exclusion criteria (4 listed)
- Cognitive limitations that limit the ability to provide informed consent
- Pregnancy
- Unable to speak or read English
- Planning to relocate during the study period
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Web-Based Storytelling InterventionThe Web-based storytelling group will access stories and educational materials on the study website. | Behavioural | Storytelling (Web-based Storytelling) |
| Group-Based Storytelling Plus InterventionThe storytelling plus group will watch the stories in a group setting, share their experiences and have educational sessions led by a health coach. | Behavioural | Storytelling Plus (Group-based Storytelling) |
Primary outcome
Systolic and Diastolic Blood Pressure
Time frame: 6 months
Blood pressure will be measured three times using a manual blood pressure monitor.
Adherence to Antihypertensive Medications (daily usage)
Time frame: 6 months
Medication adherence will be measured using Medication Electronic Measuring System (MEMS) caps
Adherence to Antihypertensive Medications (self reported)
Time frame: 6 months
Medication adherence will be measure through participant self report Domains of Subjective Extent of Nonadherence scale.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Web-Based Storytelling Intervention and Group-Based Storytelling Plus Intervention in people with Hypertension, run by University of Delaware at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 17 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Systolic and Diastolic Blood Pressure (time frame: 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2025.